Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Promisemed Hangzhou Meditech CoBJSE:920069 18 Operating Margin % is 28.48% as of Jun. 2026, which is 9% above its 10-year median of 26.09. GuruFocus rates BJSE:920069 with a GF Score™ of 18/100. The stock has 1 warning sign investors should review. Among 815 Medical Devices & Instruments companies, Promisemed Hangzhou Meditech Co ranks worse than 70.67% on this metric.
The historical rank and industry rank for Promisemed Hangzhou Meditech Co's Operating Margin % or its related term are showing as below:
BJSE:920069'
s Operating Margin % Range Over the Past 10 Years
Min: -17.54 Med: 26.09 Max: 28.24
Current: -17.54
BJSE:920069's Operating Margin % is ranked worse than 70.67% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: 3.56
vs BJSE:920069: -17.54
Promisemed Hangzhou Meditech Co (BJSE:920069) Operating Margin % Explanation
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Promisemed Hangzhou Meditech Co Operating Margin % Related Terms
Promisemed Hangzhou Meditech Co Operating Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Promisemed Hangzhou Meditech Co Operating Margin % Chart
BJSE:920069 vs ISRG, BDX, RMD: Operating Margin % Comparison
For the Medical Instruments & Supplies subindustry, Promisemed Hangzhou Meditech Co's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Promisemed Hangzhou Meditech Co Operating Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Promisemed Hangzhou Meditech Co's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Promisemed Hangzhou Meditech Co's Operating Margin % falls into.
Promisemed Hangzhou Meditech Co Operating Margin % Calculation
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Promisemed Hangzhou Meditech Co (BJSE:920069) has a Operating Margin % of 28.48% as of Jun. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Promisemed Hangzhou Meditech Co and its competitors. This is near median its historical median of 26.09. According to the industry distribution chart, Promisemed Hangzhou Meditech Co ranks #576 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 70.7%.
Is Promisemed Hangzhou Meditech Co's Operating Margin % too high?
Promisemed Hangzhou Meditech Co's current Operating Margin % of 28.48% is near median its 10-year median of 26.09. The Medical Devices & Instruments industry median Operating Margin % is 3.56. Promisemed Hangzhou Meditech Co's value of 28.48% is 700% above this industry median. Based on the distribution chart, Promisemed Hangzhou Meditech Co ranks #576 out of 815 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Promisemed Hangzhou Meditech Co has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Promisemed Hangzhou Meditech Co's Operating Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Promisemed Hangzhou Meditech Co ranks #576 out of 815 companies for Operating Margin %. This places Promisemed Hangzhou Meditech Co in the lower half of its industry. The industry median Operating Margin % is 3.56. Promisemed Hangzhou Meditech Co's value of 28.48% is 700% above this benchmark. While the company's 10-year median is 26.09 vs. the industry median of 3.56, Promisemed Hangzhou Meditech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Medical Devices & Instruments company?
The median Operating Margin % among Medical Devices & Instruments companies is 3.56, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Promisemed Hangzhou Meditech Co's current Operating Margin % of 28.48% is 700% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Promisemed Hangzhou Meditech Co and its competitors. For the Medical Devices & Instruments industry, the median Operating Margin % is 3.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Promisemed Hangzhou Meditech Co's current Operating Margin % is 28.48%, which is near median its own 10-year median of 26.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Promisemed Hangzhou Meditech Co stock overvalued right now?
Promisemed Hangzhou Meditech Co (BJSE:920069) has a current Operating Margin % of 28.48%. The current Operating Margin % is 28.48%, which is near median its 10-year median of 26.09 and 700% above the Medical Devices & Instruments industry median of 3.56. Promisemed Hangzhou Meditech Co's overall GF Score™ is 18/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Promisemed Hangzhou Meditech Co (BJSE:920069), the current Operating Margin % is 28.48% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Promisemed Hangzhou Meditech Co Ltd is engaged in the Research, development, production and sales of diabetes care, universal drug delivery and infusion, and minimally invasive interventional medical devices.
18GF Score
Get the complete analysis for BJSE:920069
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920069 has been successfully added to your 
